Initially criticized for his ties to the pharmaceutical industry, Gottlieb, a former venture capitalist, became known for his aggressive regulatory stance in the Trump administration.
The New York Times
By SHEILA KAPLAN and JAN HOFFMAN from NYT Health https://ift.tt/2GYuoss
March 4, 2019 at 02:00PM
No comments:
Post a Comment